Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Quest Diagnostics Inc (DGX) vs Kyndryl Holdings Inc (KD) Price & Performance

Quest Diagnostics IncTrade
Kyndryl Holdings IncTrade

Price performance (Past 24H)

Key statistics

Quest Diagnostics Inc vs Kyndryl Holdings Inc — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while Kyndryl Holdings Inc trades at $13.26 (market cap $2.91B). The key difference: Quest Diagnostics Inc is far larger — about 9× Kyndryl Holdings Inc's market cap, and Quest Diagnostics Inc pays a 1.45% dividend while Kyndryl Holdings Inc pays none. Which is the better fit depends on your goals.

DGXKD
Market Cap
$26.21B$2.91B
Sector
HealthTechnology
52-Week High
$238.50$33.14
52-Week Low
$173.49$10.59
Enterprise Value
$31.97B$5.74B
Dividend Yield
1.45%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Quest Diagnostics Inc

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

Read more on DGX

About Kyndryl Holdings Inc

Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives.

Read more on KD